| Breakdown | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 690.10M | 718.20M | 733.80M | 749.20M | 694.50M |
| Gross Profit | 259.00M | 336.50M | 339.50M | 350.20M | 313.20M |
| EBITDA | -18.20M | 135.80M | 141.50M | 154.20M | 123.80M |
| Net Income | -99.80M | 47.50M | -27.70M | 62.70M | 41.20M |
Balance Sheet | |||||
| Total Assets | 1.04B | 1.21B | 1.32B | 1.48B | 1.35B |
| Cash, Cash Equivalents and Short-Term Investments | 32.60M | 61.50M | 76.20M | 101.20M | 92.50M |
| Total Debt | 80.50M | 101.60M | 86.10M | 76.00M | 98.70M |
| Total Liabilities | 277.70M | 306.90M | 328.50M | 334.60M | 336.30M |
| Stockholders Equity | 763.20M | 899.60M | 987.30M | 1.14B | 1.01B |
Cash Flow | |||||
| Free Cash Flow | 61.20M | 32.20M | 67.20M | 96.60M | 61.10M |
| Operating Cash Flow | 64.60M | 75.30M | 107.50M | 126.20M | 84.30M |
| Investing Cash Flow | -20.60M | -17.70M | -71.20M | -43.70M | 23.90M |
| Financing Cash Flow | -71.70M | -67.10M | -56.10M | -81.80M | -65.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £2.13B | 13.52 | 20.41% | 2.58% | 11.42% | -17.18% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | £282.83M | -0.96 | -12.22% | 15.28% | -3.91% | -310.36% | |
60 Neutral | £234.90M | 29.89 | 4.06% | 1.52% | 15.22% | 1.23% | |
57 Neutral | £282.46M | -6.40 | -25.61% | 1.11% | 15.27% | -73.02% | |
54 Neutral | £330.14M | 275.23 | 0.58% | 2.31% | 6.90% | 145.00% | |
41 Neutral | £318.50M | -2.81 | -142.88% | ― | -4.87% | ― |